DSE:SQURPHARMA Statistics

Total Valuation

DSE:SQURPHARMA has a market cap or net worth of BDT 185.53 billion. The enterprise value is 126.47 billion.

Market Cap	185.53B
Enterprise Value	126.47B

Important Dates

The last earnings date was Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

DSE:SQURPHARMA has 886.45 million shares outstanding.

Current Share Class	886.45M
Shares Outstanding	886.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	35.97%
Owned by Institutions (%)	4.55%
Float	567.55M

Valuation Ratios

The trailing PE ratio is 7.89 and the forward PE ratio is 7.67.

PE Ratio	7.89
Forward PE	7.67
PS Ratio	2.45
PB Ratio	1.38
P/TBV Ratio	1.38
P/FCF Ratio	22.65
P/OCF Ratio	13.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.22, with an EV/FCF ratio of 15.44.

EV / Earnings	5.38
EV / Sales	1.67
EV / EBITDA	5.22
EV / EBIT	5.74
EV / FCF	15.44

Financial Position

The company has a current ratio of 12.12, with a Debt / Equity ratio of 0.01.

Current Ratio	12.12
Quick Ratio	9.53
Debt / Equity	0.01
Debt / EBITDA	0.05
Debt / FCF	0.12
Interest Coverage	74.65

Financial Efficiency

Return on equity (ROE) is 18.33% and return on invested capital (ROIC) is 8.97%.

Return on Equity (ROE)	18.33%
Return on Assets (ROA)	8.61%
Return on Invested Capital (ROIC)	8.97%
Return on Capital Employed (ROCE)	13.72%
Revenue Per Employee	6.09M
Profits Per Employee	1.89M
Employee Count	12,453
Asset Turnover	0.56
Inventory Turnover	3.11

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.55% in the last 52 weeks. The beta is 0.16, so DSE:SQURPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	-1.55%
50-Day Moving Average	216.66
200-Day Moving Average	219.85
Relative Strength Index (RSI)	23.73
Average Volume (20 Days)	174,313

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:SQURPHARMA had revenue of BDT 75.86 billion and earned 23.50 billion in profits. Earnings per share was 26.51.

Revenue	75.86B
Gross Profit	34.01B
Operating Income	18.59B
Pretax Income	27.86B
Net Income	23.50B
EBITDA	20.80B
EBIT	18.59B
Earnings Per Share (EPS)	26.51

Full Income Statement

Balance Sheet

The company has 50.52 billion in cash and 977.79 million in debt, giving a net cash position of 59.07 billion or 66.64 per share.

Cash & Cash Equivalents	50.52B
Total Debt	977.79M
Net Cash	59.07B
Net Cash Per Share	66.64
Equity (Book Value)	134.69B
Book Value Per Share	151.94
Working Capital	68.11B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.72 billion and capital expenditures -5.53 billion, giving a free cash flow of 8.19 billion.

Operating Cash Flow	13.72B
Capital Expenditures	-5.53B
Free Cash Flow	8.19B
FCF Per Share	9.24

Full Cash Flow Statement

Margins

Gross margin is 44.84%, with operating and profit margins of 24.51% and 30.98%.

Gross Margin	44.84%
Operating Margin	24.51%
Pretax Margin	36.72%
Profit Margin	30.98%
EBITDA Margin	27.42%
EBIT Margin	24.51%
FCF Margin	10.80%

Dividends & Yields

This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 5.18%.

Dividend Per Share	11.00
Dividend Yield	5.18%
Dividend Growth (YoY)	4.76%
Years of Dividend Growth	7
Payout Ratio	41.12%
Buyback Yield	n/a
Shareholder Yield	5.18%
Earnings Yield	12.67%
FCF Yield	4.42%

Dividend Details

Stock Splits

The last stock split was on November 23, 2020. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 23, 2020
Split Type	Forward
Split Ratio	1.05

Scores

DSE:SQURPHARMA has an Altman Z-Score of 19.4.

Altman Z-Score	19.4
Piotroski F-Score	n/a